Skip to main content

Peritoneal Carcinomatosis

What is peritoneal surface malignancy?

Peritoneal surface malignancy, or peritoneal carcinomatosis, is an advanced cancer that affects the peritoneum. The peritoneum is the thin lining of the abdominal cavity that protects organs, including the stomach, liver, bladder and intestines. The peritoneum supports and holds organs in place. Carcinomatosis is a form of cancer that affects a membrane or lining in the body, like peritoneal carcinomatosis.

Alternative names

Peritoneal metastasis, peritoneal cancer, peritoneum carcinomatosis

What causes peritoneal carcinomatosis?

Peritoneal carcinomatosis is often secondary to an existing cancer in one of the organs. As the primary cancer spreads within the affected organ, it may invade the peritoneum and rapidly spread along the membrane.

The biggest risk factor for peritoneal carcinomatosis is advanced-stage abdominally located cancers, including:

Though peritoneal carcinomatosis can occur on its own, it is extremely rare.

How is peritoneal carcinomatosis treated?

UF Health’s nationally recognized oncology program offers hyperthermic intraperitoneal chemotherapy, or HIPEC. This highly specialized treatment can be used to treat peritoneal carcinomatosis. UF Health is one of only a few organizations in North Florida to offer HIPEC as a treatment option for peritoneal carcinomatosis.

HIPEC allows for the surgical removal of tumors and chemotherapy at the same time. HIPEC is a viable option for advanced cancers located in the abdomen, for which traditional chemotherapy may not be the best option.

HIPEC treatment starts with cytoreductive surgery, or CRS. Cytoreductive surgery is the removal of visible tumors in the abdominal cavity. CRS is also evaluates how the cancer is affecting nearby abdominal organs, including:

  • Bowels
  • Liver
  • Ovaries
  • Spleen
  • Stomach
  • Uterus

HIPEC’s localized treatment typically creates fewer side effects, such as hair loss and immunosuppression, than traditional chemotherapy, which is administered throughout the entire body.

NCI Cancer Center badge

In 2023, the UF Health Cancer Institute became the only cancer center at a public university in Florida to receive designation from the National Cancer Institute (NCI). This prestigious status is awarded only to centers that demonstrate exceptional excellence in research and innovation, particularly in developing advanced methods for diagnosing and treating cancer. Achieving NCI designation brings UF Health closer to its goal of a future in which every patient can access personalized therapies and leading-edge clinical trials, ultimately easing the impact of cancer both in our community and beyond.

Our experts

Independent doctors are not employed by UF Health, but may provide medical care at one of our locations.